TWiV 1291: A foot in the door for cytomegalovirus

Poliovirus eradication efforts face significant hurdles as the novel oral poliovirus vaccine (nOPV2) demonstrates unexpected genetic instability. While intended to prevent reversion, nOPV2 frequently recombines with other enteroviruses in the gut, shedding its attenuating modifications and regaining neurovirulence. Parallel research into human cytomegalovirus (HCMV) reveals that latency in monocytes is primarily a consequence of inefficient viral entry rather than intracellular chromatin silencing. Productive infection in macrophages occurs because these cells express specific surface proteins, such as ITGB3, that facilitate higher viral genome uptake. Beyond these technical findings, the discussion highlights the urgent need for robust vaccination infrastructure, noting that vaccine hesitancy and the rejection of established medical guidelines pose severe risks to public health, particularly in vulnerable populations.